ANGIOTECH

angiotech-logo

Angiotech is a global specialty pharmaceutical and medical device company that discovers develops and markets innovative technologies & medical products.

#SimilarOrganizations #Website #More

ANGIOTECH

Social Links:

Industry:
Health Care Medical Medical Device Pharmaceutical

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.angiotech.com

Total Employee:
1001+

Status:
Active

Contact:
+1 604 221 7676

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Sitelinks Search Box Yoast WordPress SEO Plugin


Similar Organizations

not_available_image

BriovaRx

BriovaRx is a company that specializes in leading pharmacy care services & health care service.

essen-technology-logo

Essen Technology

Essen Technology is a company specialized in medical device research and development services.

not_available_image

Leisegang Medical, Inc

Leisegang Medical, Inc. was a company specializing in medical devices for women's health.

Official Site Inspections

http://www.angiotech.com

  • Host name: 109-234-160-247.reverse.odns.fr
  • IP address: 109.234.160.247
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "Angiotech"

Angiotech Pharmaceuticals - Wikipedia

Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury. In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adheโ€ฆSee details»

Angiotech Pharmaceuticals - Crunchbase Company โ€ฆ

Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty โ€ฆSee details»

Organizational Chart of Angiotech Pharmaceuticals, โ€ฆ

Corporate Organization . as of June 4, 2012 . Angiotech Pharmaceuticals, Inc. (British Columbia, Canada) Angiotech International Holdings, Corp. (Nova Scotia, Canada) Angiotech International AG (Switzerland) Angiodevice International โ€ฆSee details»

Angiotech - Crunchbase Company Profile & Funding

Angiotech is a global specialty pharmaceutical and medical device company that discovers develops and markets innovative technologies & medical products. Lists Featuring This Company. Edit Lists Featuring This Company Section. โ€ฆSee details»

Angiotech Pharmaceuticals, Inc. - Vancouver, Canada - bionity.com

Mar 12, 2009 Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and โ€ฆSee details»

ANGIOTECH PHARMACEUTICAL - VentureRadar

Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local โ€ฆSee details»

Angiotech Pharmaceuticals - Overview, News & Similar companies ...

Jan 20, 2021 Some of the popular technologies that Angiotech Pharmaceuticals uses are: Facebook Web Custom Audiences, WooCommerce, WordPress.org, PHP What does โ€ฆSee details»

Angiotech Pharmaceuticals - Updates, News, Events, Signals

Jun 21, 2024 Angiotech Pharmaceuticals Inc's creditors approved a restructuring plan to reduce its debt by $250 million. Additionally, the company reported a second-quarter share loss and a โ€ฆSee details»

Ailing Angiotech delisted from TSX, files for creditor protection

Jan 29, 2011 Angiotech was trading at 15 cents when halted on Friday, and had a one-year high of 79 cents last September. [email protected]. Article content. Share this article โ€ฆSee details»

Angiotech Pharmaceuticals, Inc. (ANPI) Announces Reorganization โ€ฆ

Sep 22, 2008 Angiotech Pharmaceuticals, Inc. (ANPI) Announces Reorganization and Cost Reduction Initiatives; Closes R&D Facility; Cuts Jobs VANCOUVER, Sept. 22 /CNW/ - โ€ฆSee details»

Angiotech Pharmaceuticals - chemeurope.com

Angiotech TSX: ANP is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of โ€ฆSee details»

B.C. Biotech on Life Support - BC Business

Sep 5, 2011 The revolutionary combination of drug and device was released in Europe in 2003, won regulatory approval to enter the critical U.S. market in 2004, and went on to be sold by the โ€ฆSee details»

Angiotech Pharmaceuticals - Contacts, Employees, Board Members ...

Angiotech Pharmaceuticals has 2 board members and advisors, including Bradley Karro. Contacts. Edit Contacts Section. Job Department. Protected Content. Vice President of โ€ฆSee details»

Angiotech Pharmaceuticals, Inc. announces transaction with โ€ฆ

Apr 5, 2012 Angiotech Pharmaceuticals, Inc. ("Angiotech") announced today that it had concluded the sale of certain Quill intellectual property to Ethicon, Inc. ("Ethicon"), a unit of โ€ฆSee details»

Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported ...

Oct 30, 2010 Holders of common stock of Angiotech on the date the recapitalization transaction is completed will hold 2.5% of the issued and outstanding common stock of Angiotech, as well โ€ฆSee details»

Angiotech gets FDA clearance for dialysis catheter - The Toronto Star

Aug 29, 2007 VANCOUVER โ€“ Angiotech Pharmaceuticals Inc. (TSX: ANP ) announced Wednesday it has received approval from the U.S. Food and Drug Administration to begin โ€ฆSee details»

Angiotech - Funding, Financials, Valuation & Investors - Crunchbase

Aug 29, 2013 Angiotech is a worldwide company specializing in medical devices and pharmaceuticals. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. โ€ฆSee details»

Angiotech Pharmaceuticals, Inc. announces transaction with โ€ฆ

Apr 4, 2012 Angiotech to Receive Initial Cash Consideration of $20 Million and Up to $42 Million in Potential Contingent Consideration. Angiotech to Retain Rights to Manufacture, Market and โ€ฆSee details»

Strategic Cooperation | RainMed Medical and Angiotec Signed a โ€ฆ

Aug 19, 2022 This time, Angiotech will carry out in-depth and multi-level strategic cooperation with R ainMed Medical, jointly create innovative scientific research product s, promote product โ€ฆSee details»

Angiotech biopsy device system wins FDA nod - NS ... - NS โ€ฆ

Dec 21, 2012 Angiotech Pharmaceuticals president and CEO Thomas Bailey said the device has also shown to significantly reduce complication rates in patients receiving a lung biopsy โ€ฆSee details»

linkstock.net © 2022. All rights reserved